RIZZETTO, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 3.106
AS - Asia 1.387
EU - Europa 1.158
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 126
AF - Africa 96
OC - Oceania 3
Totale 6.146
Nazione #
US - Stati Uniti d'America 3.002
SG - Singapore 418
IT - Italia 395
VN - Vietnam 315
CN - Cina 278
RU - Federazione Russa 252
BR - Brasile 211
HK - Hong Kong 172
IE - Irlanda 83
FR - Francia 82
SE - Svezia 71
GB - Regno Unito 64
CA - Canada 59
DE - Germania 55
FI - Finlandia 40
CI - Costa d'Avorio 38
BD - Bangladesh 35
IN - India 35
NL - Olanda 30
AR - Argentina 20
JP - Giappone 20
MX - Messico 20
IQ - Iraq 19
ZA - Sudafrica 19
ES - Italia 18
MA - Marocco 18
PL - Polonia 17
TR - Turchia 17
EC - Ecuador 13
AT - Austria 10
LT - Lituania 10
PH - Filippine 10
BE - Belgio 9
ID - Indonesia 9
IL - Israele 9
CL - Cile 7
PK - Pakistan 7
UZ - Uzbekistan 7
VE - Venezuela 7
TH - Thailandia 6
SA - Arabia Saudita 5
SC - Seychelles 5
CO - Colombia 4
CZ - Repubblica Ceca 4
MY - Malesia 4
TN - Tunisia 4
AU - Australia 3
CR - Costa Rica 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
NI - Nicaragua 3
PY - Paraguay 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UA - Ucraina 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
GH - Ghana 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.023
Città #
Ashburn 688
Singapore 271
San Jose 222
Dallas 216
Council Bluffs 183
Chandler 171
Hong Kong 168
Des Moines 141
Ho Chi Minh City 115
Boardman 100
New York 93
Los Angeles 84
Dublin 75
Hanoi 69
The Dalles 68
Rome 58
Beijing 53
Moscow 48
Phoenix 46
Lauterbourg 42
Abidjan 38
Ancona 36
Munich 33
Chicago 32
Hefei 32
Santa Clara 30
Buffalo 29
Milan 25
Helsinki 22
Montreal 21
Seattle 21
Orem 20
Washington 20
Shanghai 19
São Paulo 19
Da Nang 18
Tokyo 18
Turku 17
Warsaw 17
Boydton 16
Columbus 16
London 16
Princeton 16
Brooklyn 15
Fairfield 15
Houston 15
Lawrence 15
Johannesburg 14
Chennai 13
Irvington 12
San Diego 12
Stockholm 12
Atlanta 11
Haiphong 11
Nuremberg 11
Amsterdam 10
Denver 10
Kazan' 10
San Francisco 10
Toronto 10
Woodbridge 9
Baghdad 8
Boston 8
Brussels 8
Manchester 8
Salt Lake City 8
Wuhan 8
Charlotte 7
Falls Church 7
San Mateo 7
Turin 7
Wilmington 7
Biên Hòa 6
Bắc Ninh 6
Clovis 6
Elk Grove Village 6
Guangzhou 6
Guayaquil 6
Hải Dương 6
Jakarta 6
Naples 6
Porto Alegre 6
Redmond 6
Rio de Janeiro 6
Tashkent 6
Urbisaglia 6
Ankara 5
Bangkok 5
Cambridge 5
Detroit 5
Florence 5
Mexico City 5
Miano 5
Mumbai 5
Philadelphia 5
Vienna 5
Ann Arbor 4
Belton 4
Botticino 4
Bowie 4
Totale 3.890
Nome #
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 253
Oxidative stress and alterations of paraoxonases in atopic dermatitis 168
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 161
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 149
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 149
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 144
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 143
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 142
Review: A safety profile of dalbavancin for onand off-label utilization 141
The less-known face of dupilumab: its role in mesenchymal stem cells by interleukin-13 modulation 141
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 139
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 138
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 138
Biological treatments for pediatric psoriasis: state of the art and future perspectives 136
Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study 136
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 133
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 133
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 132
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy 131
Bullous Pemphygoid and Novel Therapeutic Approaches 129
Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review 129
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 128
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 128
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review 127
The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues 126
CT patterns of interstitial lung disease in patients with plaque psoriasis: a retrospective case series study 126
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 123
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 122
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 121
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience 119
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 117
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 115
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 115
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma 114
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma 112
Bimekizumab in hidradenitis suppurativa: a valid and rapid emerging treatment 111
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi 111
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 109
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 109
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 107
Role of daptomycin in cutaneous wound healing: a narrative review 105
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 101
Role of antioxidants supplementation in the treatment of atopic dermatitis: a critical narrative review 98
MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives 94
Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review 89
New insight into old and new antimicrobial molecules targeting quorum sensing for MRSA wound infection 87
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 82
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study 75
New perspectives on old and new therapies of staphylococcal skin infections: the role of biofilm targeting in wound healing. 71
Valutazione dei cambiamenti dermoscopici dopo trattamento con complessi ibridi cooperativi di acido ialuronico nelle donne affette da lichen sclerosus vulvare: studio osservazionale prospettico 39
Totale 6.146
Categoria #
all - tutte 28.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022129 0 0 0 0 16 7 2 3 13 3 47 38
2022/2023563 28 44 25 54 32 194 0 23 91 2 43 27
2023/2024503 53 8 64 64 65 120 15 41 4 23 5 41
2024/20251.056 142 67 37 8 48 41 117 36 203 76 162 119
2025/20263.114 245 170 232 304 292 196 664 235 243 287 130 116
2026/2027729 138 93 115 347 36 0 0 0 0 0 0 0
Totale 6.146